Long-term survival in a patient with chronic myelogenous leukemia without any treatment
Author | A Shahriari | en |
Author | HR Emaami | en |
Issued Date | 2002-09-20 | en |
Abstract | Chronic myelogenous leukemia (CML) is a myeloproliferative disease with a well known course. With chemotherapy, average survival of these patients is 3-5 years. All of the long term survivors of CML have been treated patients. Here we are reporting on a long term survivor (more than 10 years) without treatment. | en |
DOI | https://doi.org/ | en |
Keyword | Chronic myelogenous leukemia | en |
Keyword | survival | en |
Keyword | clinical course | en |
Publisher | Brieflands | en |
Title | Long-term survival in a patient with chronic myelogenous leukemia without any treatment | en |
Type | Case Report | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 81011.pdf
- Size:
- 276.08 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF